BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Vancouver - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://scienceinvancouver.com
X-WR-CALDESC:Events for Science in Vancouver
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210630T120000
DTEND;TZID=America/Vancouver:20210630T130000
DTSTAMP:20260407T213449
CREATED:20210614T002645Z
LAST-MODIFIED:20210614T002645Z
UID:16922-1625054400-1625058000@scienceinvancouver.com
SUMMARY:TI Methods Speaker Series: How to Improve Clinical Trial Reporting – Insights from Europe and the US
DESCRIPTION:TI Methods Speaker Series\nThe TI Methods Speaker Series are offered free of charge and everyone is welcome. The event is held at noon on the last Wednesday of each month and used to take place in Rudy North Lecture Theatre (CBH 101) in the Centre for Brain Health\, UBC Point Grey Campus. During the COVID-19 pandemic\, while physical distancing measures are in effect\, the TI Methods Speaker Series are offered via videoconference. The presentations are recorded and the video recordings are posted online.  \n\nWHEN: Wednesday\, June 30th\, 2021 from 12:00 to 1:00 PM PDT [click here to convert to your local time]\nWHERE: Offered online using Zoom. You must register in order to receive the Zoom connection details. \nTITLE: How to improve clinical trial reporting – insights from Europe and the US \nSPEAKER: Dr. Till Bruckner\, Research Fellow at the BIH QUEST Center. \n\nAbout the topic: In this presentation\, Dr. Till Bruckner will provide examples of how hidden clinical trial results undermine clinical practice and harm patients\, and present concrete examples of how the problem can be fixed in practice. Some regulators\, funders and institutions in Europe and the United States have now put systems in place that ensure that every clinical trial is registered and makes its results public – while other players are still dragging their feet. Drawing on years of experience campaigning in Europe and the United States\, the presentation will focus on what patients\, clinicians\, medical researchers and policy makers in Canada can do to build watertight systems to ensure that in future\, no clinical trial is left behind. \nAbout the speaker: Dr. Till Bruckner is a Research Fellow at the BIH QUEST Center\, where his work focuses on improving clinical trial registration and reporting. He is also the founder of TranspariMED\, a campaign that works to end evidence distortion in medicine. He previously worked for the AllTrials campaign and the anti-corruption group Transparency International. Till holds a PhD in political science from the University of Bristol\, U.K. \nAbout the TI Methods Speaker Series: The TI Methods Speaker Series are offered free of charge and everyone is welcome. The event is held at noon on the last Wednesday of each month. During the COVID-19 pandemic\, while physical distancing measures are in effect\, the TI Methods Speaker Series are offered via videoconference. The presentations are recorded and the video recordings are posted online. Click here to view the scheduled topics for 2021 and click here to view a list of TI Methods Speaker Series talks offered in 2020. \n\nBackground materials for this presentation: \n\nhttps://docs.wixstatic.com/ugd/01f35d_def0082121a648529220e1d56df4b50a.pdf\nhttps://media.wix.com/ugd/01f35d_0f2955eb88e34c02b82d886c528efeb4.pdf
URL:https://scienceinvancouver.com/event/ti-methods-speaker-series-how-to-improve-clinical-trial-reporting-insights-from-europe-and-the-us/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210630T120000
DTEND;TZID=America/Vancouver:20210630T130000
DTSTAMP:20260407T213449
CREATED:20210614T002645Z
LAST-MODIFIED:20210614T002645Z
UID:26399-1625054400-1625058000@scienceinvancouver.com
SUMMARY:TI Methods Speaker Series: How to Improve Clinical Trial Reporting – Insights from Europe and the US
DESCRIPTION:TI Methods Speaker Series\nThe TI Methods Speaker Series are offered free of charge and everyone is welcome. The event is held at noon on the last Wednesday of each month and used to take place in Rudy North Lecture Theatre (CBH 101) in the Centre for Brain Health\, UBC Point Grey Campus. During the COVID-19 pandemic\, while physical distancing measures are in effect\, the TI Methods Speaker Series are offered via videoconference. The presentations are recorded and the video recordings are posted online.  \n\nWHEN: Wednesday\, June 30th\, 2021 from 12:00 to 1:00 PM PDT [click here to convert to your local time]\nWHERE: Offered online using Zoom. You must register in order to receive the Zoom connection details. \nTITLE: How to improve clinical trial reporting – insights from Europe and the US \nSPEAKER: Dr. Till Bruckner\, Research Fellow at the BIH QUEST Center. \n\nAbout the topic: In this presentation\, Dr. Till Bruckner will provide examples of how hidden clinical trial results undermine clinical practice and harm patients\, and present concrete examples of how the problem can be fixed in practice. Some regulators\, funders and institutions in Europe and the United States have now put systems in place that ensure that every clinical trial is registered and makes its results public – while other players are still dragging their feet. Drawing on years of experience campaigning in Europe and the United States\, the presentation will focus on what patients\, clinicians\, medical researchers and policy makers in Canada can do to build watertight systems to ensure that in future\, no clinical trial is left behind. \nAbout the speaker: Dr. Till Bruckner is a Research Fellow at the BIH QUEST Center\, where his work focuses on improving clinical trial registration and reporting. He is also the founder of TranspariMED\, a campaign that works to end evidence distortion in medicine. He previously worked for the AllTrials campaign and the anti-corruption group Transparency International. Till holds a PhD in political science from the University of Bristol\, U.K. \nAbout the TI Methods Speaker Series: The TI Methods Speaker Series are offered free of charge and everyone is welcome. The event is held at noon on the last Wednesday of each month. During the COVID-19 pandemic\, while physical distancing measures are in effect\, the TI Methods Speaker Series are offered via videoconference. The presentations are recorded and the video recordings are posted online. Click here to view the scheduled topics for 2021 and click here to view a list of TI Methods Speaker Series talks offered in 2020. \n\nBackground materials for this presentation: \n\nhttps://docs.wixstatic.com/ugd/01f35d_def0082121a648529220e1d56df4b50a.pdf\nhttps://media.wix.com/ugd/01f35d_0f2955eb88e34c02b82d886c528efeb4.pdf
URL:https://scienceinvancouver.com/event/ti-methods-speaker-series-how-to-improve-clinical-trial-reporting-insights-from-europe-and-the-us-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210630T120000
DTEND;TZID=America/Vancouver:20210630T130000
DTSTAMP:20260407T213449
CREATED:20210614T002645Z
LAST-MODIFIED:20210614T002645Z
UID:28014-1625054400-1625058000@scienceinvancouver.com
SUMMARY:TI Methods Speaker Series: How to Improve Clinical Trial Reporting – Insights from Europe and the US
DESCRIPTION:TI Methods Speaker Series\nThe TI Methods Speaker Series are offered free of charge and everyone is welcome. The event is held at noon on the last Wednesday of each month and used to take place in Rudy North Lecture Theatre (CBH 101) in the Centre for Brain Health\, UBC Point Grey Campus. During the COVID-19 pandemic\, while physical distancing measures are in effect\, the TI Methods Speaker Series are offered via videoconference. The presentations are recorded and the video recordings are posted online.  \n\nWHEN: Wednesday\, June 30th\, 2021 from 12:00 to 1:00 PM PDT [click here to convert to your local time]\nWHERE: Offered online using Zoom. You must register in order to receive the Zoom connection details. \nTITLE: How to improve clinical trial reporting – insights from Europe and the US \nSPEAKER: Dr. Till Bruckner\, Research Fellow at the BIH QUEST Center. \n\nAbout the topic: In this presentation\, Dr. Till Bruckner will provide examples of how hidden clinical trial results undermine clinical practice and harm patients\, and present concrete examples of how the problem can be fixed in practice. Some regulators\, funders and institutions in Europe and the United States have now put systems in place that ensure that every clinical trial is registered and makes its results public – while other players are still dragging their feet. Drawing on years of experience campaigning in Europe and the United States\, the presentation will focus on what patients\, clinicians\, medical researchers and policy makers in Canada can do to build watertight systems to ensure that in future\, no clinical trial is left behind. \nAbout the speaker: Dr. Till Bruckner is a Research Fellow at the BIH QUEST Center\, where his work focuses on improving clinical trial registration and reporting. He is also the founder of TranspariMED\, a campaign that works to end evidence distortion in medicine. He previously worked for the AllTrials campaign and the anti-corruption group Transparency International. Till holds a PhD in political science from the University of Bristol\, U.K. \nAbout the TI Methods Speaker Series: The TI Methods Speaker Series are offered free of charge and everyone is welcome. The event is held at noon on the last Wednesday of each month. During the COVID-19 pandemic\, while physical distancing measures are in effect\, the TI Methods Speaker Series are offered via videoconference. The presentations are recorded and the video recordings are posted online. Click here to view the scheduled topics for 2021 and click here to view a list of TI Methods Speaker Series talks offered in 2020. \n\nBackground materials for this presentation: \n\nhttps://docs.wixstatic.com/ugd/01f35d_def0082121a648529220e1d56df4b50a.pdf\nhttps://media.wix.com/ugd/01f35d_0f2955eb88e34c02b82d886c528efeb4.pdf
URL:https://scienceinvancouver.com/event/ti-methods-speaker-series-how-to-improve-clinical-trial-reporting-insights-from-europe-and-the-us-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210630T120000
DTEND;TZID=America/Vancouver:20210630T130000
DTSTAMP:20260407T213449
CREATED:20210614T002645Z
LAST-MODIFIED:20210614T002645Z
UID:31097-1625054400-1625058000@scienceinvancouver.com
SUMMARY:TI Methods Speaker Series: How to Improve Clinical Trial Reporting – Insights from Europe and the US
DESCRIPTION:TI Methods Speaker Series\nThe TI Methods Speaker Series are offered free of charge and everyone is welcome. The event is held at noon on the last Wednesday of each month and used to take place in Rudy North Lecture Theatre (CBH 101) in the Centre for Brain Health\, UBC Point Grey Campus. During the COVID-19 pandemic\, while physical distancing measures are in effect\, the TI Methods Speaker Series are offered via videoconference. The presentations are recorded and the video recordings are posted online.  \n\nWHEN: Wednesday\, June 30th\, 2021 from 12:00 to 1:00 PM PDT [click here to convert to your local time]\nWHERE: Offered online using Zoom. You must register in order to receive the Zoom connection details. \nTITLE: How to improve clinical trial reporting – insights from Europe and the US \nSPEAKER: Dr. Till Bruckner\, Research Fellow at the BIH QUEST Center. \n\nAbout the topic: In this presentation\, Dr. Till Bruckner will provide examples of how hidden clinical trial results undermine clinical practice and harm patients\, and present concrete examples of how the problem can be fixed in practice. Some regulators\, funders and institutions in Europe and the United States have now put systems in place that ensure that every clinical trial is registered and makes its results public – while other players are still dragging their feet. Drawing on years of experience campaigning in Europe and the United States\, the presentation will focus on what patients\, clinicians\, medical researchers and policy makers in Canada can do to build watertight systems to ensure that in future\, no clinical trial is left behind. \nAbout the speaker: Dr. Till Bruckner is a Research Fellow at the BIH QUEST Center\, where his work focuses on improving clinical trial registration and reporting. He is also the founder of TranspariMED\, a campaign that works to end evidence distortion in medicine. He previously worked for the AllTrials campaign and the anti-corruption group Transparency International. Till holds a PhD in political science from the University of Bristol\, U.K. \nAbout the TI Methods Speaker Series: The TI Methods Speaker Series are offered free of charge and everyone is welcome. The event is held at noon on the last Wednesday of each month. During the COVID-19 pandemic\, while physical distancing measures are in effect\, the TI Methods Speaker Series are offered via videoconference. The presentations are recorded and the video recordings are posted online. Click here to view the scheduled topics for 2021 and click here to view a list of TI Methods Speaker Series talks offered in 2020. \n\nBackground materials for this presentation: \n\nhttps://docs.wixstatic.com/ugd/01f35d_def0082121a648529220e1d56df4b50a.pdf\nhttps://media.wix.com/ugd/01f35d_0f2955eb88e34c02b82d886c528efeb4.pdf
URL:https://scienceinvancouver.com/event/ti-methods-speaker-series-how-to-improve-clinical-trial-reporting-insights-from-europe-and-the-us-4/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210630T120000
DTEND;TZID=America/Vancouver:20210630T130000
DTSTAMP:20260407T213449
CREATED:20210614T002645Z
LAST-MODIFIED:20210614T002645Z
UID:32557-1625054400-1625058000@scienceinvancouver.com
SUMMARY:TI Methods Speaker Series: How to Improve Clinical Trial Reporting – Insights from Europe and the US
DESCRIPTION:TI Methods Speaker Series\nThe TI Methods Speaker Series are offered free of charge and everyone is welcome. The event is held at noon on the last Wednesday of each month and used to take place in Rudy North Lecture Theatre (CBH 101) in the Centre for Brain Health\, UBC Point Grey Campus. During the COVID-19 pandemic\, while physical distancing measures are in effect\, the TI Methods Speaker Series are offered via videoconference. The presentations are recorded and the video recordings are posted online.  \n\nWHEN: Wednesday\, June 30th\, 2021 from 12:00 to 1:00 PM PDT [click here to convert to your local time]\nWHERE: Offered online using Zoom. You must register in order to receive the Zoom connection details. \nTITLE: How to improve clinical trial reporting – insights from Europe and the US \nSPEAKER: Dr. Till Bruckner\, Research Fellow at the BIH QUEST Center. \n\nAbout the topic: In this presentation\, Dr. Till Bruckner will provide examples of how hidden clinical trial results undermine clinical practice and harm patients\, and present concrete examples of how the problem can be fixed in practice. Some regulators\, funders and institutions in Europe and the United States have now put systems in place that ensure that every clinical trial is registered and makes its results public – while other players are still dragging their feet. Drawing on years of experience campaigning in Europe and the United States\, the presentation will focus on what patients\, clinicians\, medical researchers and policy makers in Canada can do to build watertight systems to ensure that in future\, no clinical trial is left behind. \nAbout the speaker: Dr. Till Bruckner is a Research Fellow at the BIH QUEST Center\, where his work focuses on improving clinical trial registration and reporting. He is also the founder of TranspariMED\, a campaign that works to end evidence distortion in medicine. He previously worked for the AllTrials campaign and the anti-corruption group Transparency International. Till holds a PhD in political science from the University of Bristol\, U.K. \nAbout the TI Methods Speaker Series: The TI Methods Speaker Series are offered free of charge and everyone is welcome. The event is held at noon on the last Wednesday of each month. During the COVID-19 pandemic\, while physical distancing measures are in effect\, the TI Methods Speaker Series are offered via videoconference. The presentations are recorded and the video recordings are posted online. Click here to view the scheduled topics for 2021 and click here to view a list of TI Methods Speaker Series talks offered in 2020. \n\nBackground materials for this presentation: \n\nhttps://docs.wixstatic.com/ugd/01f35d_def0082121a648529220e1d56df4b50a.pdf\nhttps://media.wix.com/ugd/01f35d_0f2955eb88e34c02b82d886c528efeb4.pdf
URL:https://scienceinvancouver.com/event/ti-methods-speaker-series-how-to-improve-clinical-trial-reporting-insights-from-europe-and-the-us-5/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210706T100000
DTEND;TZID=America/Vancouver:20210706T110000
DTSTAMP:20260407T213449
CREATED:20210623T204255Z
LAST-MODIFIED:20210623T204255Z
UID:17058-1625565600-1625569200@scienceinvancouver.com
SUMMARY:Metadata Basics: Describing Research Data
DESCRIPTION:Metadata is information that describes a resource (i.e. data about data). When used effectively\, metadata helps with usability\, discovery\, and storage of research. After completing this workshop\, participants will be able to articulate what metadata is and how it is used\, select a metadata standard that best suits their project and discipline\, and select an appropriate tool for creating and maintaining metadata. Case studies and examples will be used to demonstrate metadata application and impact. \nThe lecture portion of this session will be from 10:00 – 11:00am. We’ll have extra time after for those who want to stay to ask questions.
URL:https://scienceinvancouver.com/event/metadata-basics-describing-research-data/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210706T100000
DTEND;TZID=America/Vancouver:20210706T110000
DTSTAMP:20260407T213449
CREATED:20210623T204255Z
LAST-MODIFIED:20210623T204255Z
UID:26404-1625565600-1625569200@scienceinvancouver.com
SUMMARY:Metadata Basics: Describing Research Data
DESCRIPTION:Metadata is information that describes a resource (i.e. data about data). When used effectively\, metadata helps with usability\, discovery\, and storage of research. After completing this workshop\, participants will be able to articulate what metadata is and how it is used\, select a metadata standard that best suits their project and discipline\, and select an appropriate tool for creating and maintaining metadata. Case studies and examples will be used to demonstrate metadata application and impact. \nThe lecture portion of this session will be from 10:00 – 11:00am. We’ll have extra time after for those who want to stay to ask questions.
URL:https://scienceinvancouver.com/event/metadata-basics-describing-research-data-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210706T100000
DTEND;TZID=America/Vancouver:20210706T110000
DTSTAMP:20260407T213449
CREATED:20210623T204255Z
LAST-MODIFIED:20210623T204255Z
UID:28019-1625565600-1625569200@scienceinvancouver.com
SUMMARY:Metadata Basics: Describing Research Data
DESCRIPTION:Metadata is information that describes a resource (i.e. data about data). When used effectively\, metadata helps with usability\, discovery\, and storage of research. After completing this workshop\, participants will be able to articulate what metadata is and how it is used\, select a metadata standard that best suits their project and discipline\, and select an appropriate tool for creating and maintaining metadata. Case studies and examples will be used to demonstrate metadata application and impact. \nThe lecture portion of this session will be from 10:00 – 11:00am. We’ll have extra time after for those who want to stay to ask questions.
URL:https://scienceinvancouver.com/event/metadata-basics-describing-research-data-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210706T100000
DTEND;TZID=America/Vancouver:20210706T110000
DTSTAMP:20260407T213449
CREATED:20210623T204255Z
LAST-MODIFIED:20210623T204255Z
UID:31102-1625565600-1625569200@scienceinvancouver.com
SUMMARY:Metadata Basics: Describing Research Data
DESCRIPTION:Metadata is information that describes a resource (i.e. data about data). When used effectively\, metadata helps with usability\, discovery\, and storage of research. After completing this workshop\, participants will be able to articulate what metadata is and how it is used\, select a metadata standard that best suits their project and discipline\, and select an appropriate tool for creating and maintaining metadata. Case studies and examples will be used to demonstrate metadata application and impact. \nThe lecture portion of this session will be from 10:00 – 11:00am. We’ll have extra time after for those who want to stay to ask questions.
URL:https://scienceinvancouver.com/event/metadata-basics-describing-research-data-4/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210706T100000
DTEND;TZID=America/Vancouver:20210706T110000
DTSTAMP:20260407T213449
CREATED:20210623T204255Z
LAST-MODIFIED:20210623T204255Z
UID:32562-1625565600-1625569200@scienceinvancouver.com
SUMMARY:Metadata Basics: Describing Research Data
DESCRIPTION:Metadata is information that describes a resource (i.e. data about data). When used effectively\, metadata helps with usability\, discovery\, and storage of research. After completing this workshop\, participants will be able to articulate what metadata is and how it is used\, select a metadata standard that best suits their project and discipline\, and select an appropriate tool for creating and maintaining metadata. Case studies and examples will be used to demonstrate metadata application and impact. \nThe lecture portion of this session will be from 10:00 – 11:00am. We’ll have extra time after for those who want to stay to ask questions.
URL:https://scienceinvancouver.com/event/metadata-basics-describing-research-data-5/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210707T110000
DTEND;TZID=America/Vancouver:20210707T120000
DTSTAMP:20260407T213449
CREATED:20210705T164644Z
LAST-MODIFIED:20210705T182313Z
UID:17250-1625655600-1625659200@scienceinvancouver.com
SUMMARY:CBR Virtual Summer Seminar Series: "Organs-on-Chip: Design Considerations and Applications"
DESCRIPTION:Dr. Karen Cheung\, Professor\nDepartment of Electrical & Computer Engineering\nDirector\, Graduate Biomedical Engineering Program & Associate Director\nMember\, Centre for Blood Research \nTopic: “Organs-on-Chip: Design Considerations and Applications”\nPresented by: Tanya Bennet\, Vinny Randhawa\, Jessica Hua and Tiffany Cameron \nOrgans-on-chips are small-scale tissues containing living cells that mimic organ structures\, and they show strong potential for improving preclinical-to-clinical translation during drug development. We are developing a microfluidic organ-on-chip model that incorporates a novel 3-dimensional extracellular matrix and an architecture comprising a epithelial layer and endothelial-lined lumen with stromal cells to model small airways in Chronic Obstructive Pulmonary Disease (COPD). We aim to characterize the response of airways-on-a-chip to woodsmoke or cigarette smoke. We will develop new microscopy methods to monitor how these tissues respond to compounds or stressors. We are also developing a microfluidic model of the brain microvasculature\, with applications for studying neurodegenerative disease. This presentation will highlight several projects in our laboratory in organs-on-chip. \n 
URL:https://scienceinvancouver.com/event/cbr-virtual-summer-seminar-series-organs-on-chip-design-considerations-and-applications/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210707T110000
DTEND;TZID=America/Vancouver:20210707T120000
DTSTAMP:20260407T213449
CREATED:20210705T164644Z
LAST-MODIFIED:20210705T164644Z
UID:26408-1625655600-1625659200@scienceinvancouver.com
SUMMARY:CBR Virtual Summer Seminar Series: "Organs-on-Chip: Design Considerations and Applications"
DESCRIPTION:Dr. Karen Cheung\, Professor\nDepartment of Electrical & Computer Engineering\nDirector\, Graduate Biomedical Engineering Program & Associate Director\nMember\, Centre for Blood Research \nTopic: “Organs-on-Chip: Design Considerations and Applications”\nPresented by: Tanya Bennet\, Vinny Randhawa\, Jessica Hua and Tiffany Cameron \nOrgans-on-chips are small-scale tissues containing living cells that mimic organ structures\, and they show strong potential for improving preclinical-to-clinical translation during drug development. We are developing a microfluidic organ-on-chip model that incorporates a novel 3-dimensional extracellular matrix and an architecture comprising a epithelial layer and endothelial-lined lumen with stromal cells to model small airways in Chronic Obstructive Pulmonary Disease (COPD). We aim to characterize the response of airways-on-a-chip to woodsmoke or cigarette smoke. We will develop new microscopy methods to monitor how these tissues respond to compounds or stressors. We are also developing a microfluidic model of the brain microvasculature\, with applications for studying neurodegenerative disease. This presentation will highlight several projects in our laboratory in organs-on-chip. \n 
URL:https://scienceinvancouver.com/event/cbr-virtual-summer-seminar-series-organs-on-chip-design-considerations-and-applications-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210707T110000
DTEND;TZID=America/Vancouver:20210707T120000
DTSTAMP:20260407T213449
CREATED:20210705T164644Z
LAST-MODIFIED:20210705T164644Z
UID:28023-1625655600-1625659200@scienceinvancouver.com
SUMMARY:CBR Virtual Summer Seminar Series: "Organs-on-Chip: Design Considerations and Applications"
DESCRIPTION:Dr. Karen Cheung\, Professor\nDepartment of Electrical & Computer Engineering\nDirector\, Graduate Biomedical Engineering Program & Associate Director\nMember\, Centre for Blood Research \nTopic: “Organs-on-Chip: Design Considerations and Applications”\nPresented by: Tanya Bennet\, Vinny Randhawa\, Jessica Hua and Tiffany Cameron \nOrgans-on-chips are small-scale tissues containing living cells that mimic organ structures\, and they show strong potential for improving preclinical-to-clinical translation during drug development. We are developing a microfluidic organ-on-chip model that incorporates a novel 3-dimensional extracellular matrix and an architecture comprising a epithelial layer and endothelial-lined lumen with stromal cells to model small airways in Chronic Obstructive Pulmonary Disease (COPD). We aim to characterize the response of airways-on-a-chip to woodsmoke or cigarette smoke. We will develop new microscopy methods to monitor how these tissues respond to compounds or stressors. We are also developing a microfluidic model of the brain microvasculature\, with applications for studying neurodegenerative disease. This presentation will highlight several projects in our laboratory in organs-on-chip. \n 
URL:https://scienceinvancouver.com/event/cbr-virtual-summer-seminar-series-organs-on-chip-design-considerations-and-applications-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210707T110000
DTEND;TZID=America/Vancouver:20210707T120000
DTSTAMP:20260407T213449
CREATED:20210705T164644Z
LAST-MODIFIED:20210705T164644Z
UID:31106-1625655600-1625659200@scienceinvancouver.com
SUMMARY:CBR Virtual Summer Seminar Series: "Organs-on-Chip: Design Considerations and Applications"
DESCRIPTION:Dr. Karen Cheung\, Professor\nDepartment of Electrical & Computer Engineering\nDirector\, Graduate Biomedical Engineering Program & Associate Director\nMember\, Centre for Blood Research \nTopic: “Organs-on-Chip: Design Considerations and Applications”\nPresented by: Tanya Bennet\, Vinny Randhawa\, Jessica Hua and Tiffany Cameron \nOrgans-on-chips are small-scale tissues containing living cells that mimic organ structures\, and they show strong potential for improving preclinical-to-clinical translation during drug development. We are developing a microfluidic organ-on-chip model that incorporates a novel 3-dimensional extracellular matrix and an architecture comprising a epithelial layer and endothelial-lined lumen with stromal cells to model small airways in Chronic Obstructive Pulmonary Disease (COPD). We aim to characterize the response of airways-on-a-chip to woodsmoke or cigarette smoke. We will develop new microscopy methods to monitor how these tissues respond to compounds or stressors. We are also developing a microfluidic model of the brain microvasculature\, with applications for studying neurodegenerative disease. This presentation will highlight several projects in our laboratory in organs-on-chip. \n 
URL:https://scienceinvancouver.com/event/cbr-virtual-summer-seminar-series-organs-on-chip-design-considerations-and-applications-4/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210707T110000
DTEND;TZID=America/Vancouver:20210707T120000
DTSTAMP:20260407T213449
CREATED:20210705T164644Z
LAST-MODIFIED:20210705T164644Z
UID:32566-1625655600-1625659200@scienceinvancouver.com
SUMMARY:CBR Virtual Summer Seminar Series: "Organs-on-Chip: Design Considerations and Applications"
DESCRIPTION:Dr. Karen Cheung\, Professor\nDepartment of Electrical & Computer Engineering\nDirector\, Graduate Biomedical Engineering Program & Associate Director\nMember\, Centre for Blood Research \nTopic: “Organs-on-Chip: Design Considerations and Applications”\nPresented by: Tanya Bennet\, Vinny Randhawa\, Jessica Hua and Tiffany Cameron \nOrgans-on-chips are small-scale tissues containing living cells that mimic organ structures\, and they show strong potential for improving preclinical-to-clinical translation during drug development. We are developing a microfluidic organ-on-chip model that incorporates a novel 3-dimensional extracellular matrix and an architecture comprising a epithelial layer and endothelial-lined lumen with stromal cells to model small airways in Chronic Obstructive Pulmonary Disease (COPD). We aim to characterize the response of airways-on-a-chip to woodsmoke or cigarette smoke. We will develop new microscopy methods to monitor how these tissues respond to compounds or stressors. We are also developing a microfluidic model of the brain microvasculature\, with applications for studying neurodegenerative disease. This presentation will highlight several projects in our laboratory in organs-on-chip. \n 
URL:https://scienceinvancouver.com/event/cbr-virtual-summer-seminar-series-organs-on-chip-design-considerations-and-applications-5/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210714T110000
DTEND;TZID=America/Vancouver:20210714T123000
DTSTAMP:20260407T213449
CREATED:20210625T183945Z
LAST-MODIFIED:20210628T185824Z
UID:17116-1626260400-1626265800@scienceinvancouver.com
SUMMARY:Translating Discovery to Transform Health: Untold Stories from Medical Research
DESCRIPTION:British Columbia is home to a thriving life sciences ecosystem that made pivotal contributions to the COVID-19 response. The biotech sector in B.C. is poised to drive both the economy and healthcare of the future—yet individually\, scientists\, companies and clinicians still face seemingly insurmountable barriers to collaboration and innovation. Can you imagine a smoother path? \nHear from UBC experts Dr. Pieter Cullis\, Dr. Megan Levings and Dr. Sriram Subramaniam as they share insights from their own experiences bringing discoveries into the healthcare system\, and perspectives on how to integrate academic research and the biotech industry in B.C. to accelerate health innovation. \nClick here to register
URL:https://scienceinvancouver.com/event/translating-discovery-to-transform-health-untold-stories-from-medical-research/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210714T110000
DTEND;TZID=America/Vancouver:20210714T123000
DTSTAMP:20260407T213449
CREATED:20210625T183945Z
LAST-MODIFIED:20210625T183945Z
UID:26406-1626260400-1626265800@scienceinvancouver.com
SUMMARY:Translating Discovery to Transform Health: Untold Stories from Medical Research
DESCRIPTION:British Columbia is home to a thriving life sciences ecosystem that made pivotal contributions to the COVID-19 response. The biotech sector in B.C. is poised to drive both the economy and healthcare of the future—yet individually\, scientists\, companies and clinicians still face seemingly insurmountable barriers to collaboration and innovation. Can you imagine a smoother path? \nHear from UBC experts Dr. Pieter Cullis\, Dr. Megan Levings and Dr. Sriram Subramaniam as they share insights from their own experiences bringing discoveries into the healthcare system\, and perspectives on how to integrate academic research and the biotech industry in B.C. to accelerate health innovation. \nClick here to register
URL:https://scienceinvancouver.com/event/translating-discovery-to-transform-health-untold-stories-from-medical-research-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210714T110000
DTEND;TZID=America/Vancouver:20210714T123000
DTSTAMP:20260407T213449
CREATED:20210625T183945Z
LAST-MODIFIED:20210625T183945Z
UID:28021-1626260400-1626265800@scienceinvancouver.com
SUMMARY:Translating Discovery to Transform Health: Untold Stories from Medical Research
DESCRIPTION:British Columbia is home to a thriving life sciences ecosystem that made pivotal contributions to the COVID-19 response. The biotech sector in B.C. is poised to drive both the economy and healthcare of the future—yet individually\, scientists\, companies and clinicians still face seemingly insurmountable barriers to collaboration and innovation. Can you imagine a smoother path? \nHear from UBC experts Dr. Pieter Cullis\, Dr. Megan Levings and Dr. Sriram Subramaniam as they share insights from their own experiences bringing discoveries into the healthcare system\, and perspectives on how to integrate academic research and the biotech industry in B.C. to accelerate health innovation. \nClick here to register
URL:https://scienceinvancouver.com/event/translating-discovery-to-transform-health-untold-stories-from-medical-research-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210714T110000
DTEND;TZID=America/Vancouver:20210714T123000
DTSTAMP:20260407T213449
CREATED:20210625T183945Z
LAST-MODIFIED:20210625T183945Z
UID:31104-1626260400-1626265800@scienceinvancouver.com
SUMMARY:Translating Discovery to Transform Health: Untold Stories from Medical Research
DESCRIPTION:British Columbia is home to a thriving life sciences ecosystem that made pivotal contributions to the COVID-19 response. The biotech sector in B.C. is poised to drive both the economy and healthcare of the future—yet individually\, scientists\, companies and clinicians still face seemingly insurmountable barriers to collaboration and innovation. Can you imagine a smoother path? \nHear from UBC experts Dr. Pieter Cullis\, Dr. Megan Levings and Dr. Sriram Subramaniam as they share insights from their own experiences bringing discoveries into the healthcare system\, and perspectives on how to integrate academic research and the biotech industry in B.C. to accelerate health innovation. \nClick here to register
URL:https://scienceinvancouver.com/event/translating-discovery-to-transform-health-untold-stories-from-medical-research-4/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210714T110000
DTEND;TZID=America/Vancouver:20210714T123000
DTSTAMP:20260407T213449
CREATED:20210625T183945Z
LAST-MODIFIED:20210625T183945Z
UID:32564-1626260400-1626265800@scienceinvancouver.com
SUMMARY:Translating Discovery to Transform Health: Untold Stories from Medical Research
DESCRIPTION:British Columbia is home to a thriving life sciences ecosystem that made pivotal contributions to the COVID-19 response. The biotech sector in B.C. is poised to drive both the economy and healthcare of the future—yet individually\, scientists\, companies and clinicians still face seemingly insurmountable barriers to collaboration and innovation. Can you imagine a smoother path? \nHear from UBC experts Dr. Pieter Cullis\, Dr. Megan Levings and Dr. Sriram Subramaniam as they share insights from their own experiences bringing discoveries into the healthcare system\, and perspectives on how to integrate academic research and the biotech industry in B.C. to accelerate health innovation. \nClick here to register
URL:https://scienceinvancouver.com/event/translating-discovery-to-transform-health-untold-stories-from-medical-research-5/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210714T114500
DTEND;TZID=America/Vancouver:20210714T124500
DTSTAMP:20260407T213449
CREATED:20210707T235225Z
LAST-MODIFIED:20210707T235225Z
UID:17296-1626263100-1626266700@scienceinvancouver.com
SUMMARY:Shedding Light On the Risks of Anticholinergic Drugs: New Information on Risk of Dementia and Harm In the Frail Elderly
DESCRIPTION:Dr. Aaron M Tejani is a researcher with the Therapeutics Initiative (co-chair of the Education Working Group and the Drug Assessment Working Group)\, a clinical assistant professor with the Faculty of Pharmaceutical Sciences (University of British Columbia)\, and Medication use evaluation pharmacist with Lower Mainland Pharmacy Services (Vancouver\, BC). He completed his BSc (Pharm) at UBC (Vancouver) and Doctor of Pharmacy degree at Creighton University (Omaha\, Nebraska). \nLearning Objectives \nBy the end of this session\, participants should be able to: \n\nUtilize existing tools to determine which drugs have anticholinergic properties.\nIdentify subtle and not-so-subtle manifestations on anticholinergic drug toxicity.\nUpdate on new evidence for the risk of dementia and the risk of harm in the frail elderly\nDescribe how indication-based prescribing can help clinicians assess the patients who use anticholinergic drugs.\nUtilize informed consent to ensure patients are aware of the risks associated with use of anticholinergic drugs.
URL:https://scienceinvancouver.com/event/shedding-light-on-the-risks-of-anticholinergic-drugs-new-information-on-risk-of-dementia-and-harm-in-the-frail-elderly/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210714T114500
DTEND;TZID=America/Vancouver:20210714T124500
DTSTAMP:20260407T213449
CREATED:20210707T235225Z
LAST-MODIFIED:20210707T235225Z
UID:26413-1626263100-1626266700@scienceinvancouver.com
SUMMARY:Shedding Light On the Risks of Anticholinergic Drugs: New Information on Risk of Dementia and Harm In the Frail Elderly
DESCRIPTION:Dr. Aaron M Tejani is a researcher with the Therapeutics Initiative (co-chair of the Education Working Group and the Drug Assessment Working Group)\, a clinical assistant professor with the Faculty of Pharmaceutical Sciences (University of British Columbia)\, and Medication use evaluation pharmacist with Lower Mainland Pharmacy Services (Vancouver\, BC). He completed his BSc (Pharm) at UBC (Vancouver) and Doctor of Pharmacy degree at Creighton University (Omaha\, Nebraska). \nLearning Objectives \nBy the end of this session\, participants should be able to: \n\nUtilize existing tools to determine which drugs have anticholinergic properties.\nIdentify subtle and not-so-subtle manifestations on anticholinergic drug toxicity.\nUpdate on new evidence for the risk of dementia and the risk of harm in the frail elderly\nDescribe how indication-based prescribing can help clinicians assess the patients who use anticholinergic drugs.\nUtilize informed consent to ensure patients are aware of the risks associated with use of anticholinergic drugs.
URL:https://scienceinvancouver.com/event/shedding-light-on-the-risks-of-anticholinergic-drugs-new-information-on-risk-of-dementia-and-harm-in-the-frail-elderly-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210714T114500
DTEND;TZID=America/Vancouver:20210714T124500
DTSTAMP:20260407T213449
CREATED:20210707T235225Z
LAST-MODIFIED:20210707T235225Z
UID:28028-1626263100-1626266700@scienceinvancouver.com
SUMMARY:Shedding Light On the Risks of Anticholinergic Drugs: New Information on Risk of Dementia and Harm In the Frail Elderly
DESCRIPTION:Dr. Aaron M Tejani is a researcher with the Therapeutics Initiative (co-chair of the Education Working Group and the Drug Assessment Working Group)\, a clinical assistant professor with the Faculty of Pharmaceutical Sciences (University of British Columbia)\, and Medication use evaluation pharmacist with Lower Mainland Pharmacy Services (Vancouver\, BC). He completed his BSc (Pharm) at UBC (Vancouver) and Doctor of Pharmacy degree at Creighton University (Omaha\, Nebraska). \nLearning Objectives \nBy the end of this session\, participants should be able to: \n\nUtilize existing tools to determine which drugs have anticholinergic properties.\nIdentify subtle and not-so-subtle manifestations on anticholinergic drug toxicity.\nUpdate on new evidence for the risk of dementia and the risk of harm in the frail elderly\nDescribe how indication-based prescribing can help clinicians assess the patients who use anticholinergic drugs.\nUtilize informed consent to ensure patients are aware of the risks associated with use of anticholinergic drugs.
URL:https://scienceinvancouver.com/event/shedding-light-on-the-risks-of-anticholinergic-drugs-new-information-on-risk-of-dementia-and-harm-in-the-frail-elderly-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210714T114500
DTEND;TZID=America/Vancouver:20210714T124500
DTSTAMP:20260407T213449
CREATED:20210707T235225Z
LAST-MODIFIED:20210707T235225Z
UID:31111-1626263100-1626266700@scienceinvancouver.com
SUMMARY:Shedding Light On the Risks of Anticholinergic Drugs: New Information on Risk of Dementia and Harm In the Frail Elderly
DESCRIPTION:Dr. Aaron M Tejani is a researcher with the Therapeutics Initiative (co-chair of the Education Working Group and the Drug Assessment Working Group)\, a clinical assistant professor with the Faculty of Pharmaceutical Sciences (University of British Columbia)\, and Medication use evaluation pharmacist with Lower Mainland Pharmacy Services (Vancouver\, BC). He completed his BSc (Pharm) at UBC (Vancouver) and Doctor of Pharmacy degree at Creighton University (Omaha\, Nebraska). \nLearning Objectives \nBy the end of this session\, participants should be able to: \n\nUtilize existing tools to determine which drugs have anticholinergic properties.\nIdentify subtle and not-so-subtle manifestations on anticholinergic drug toxicity.\nUpdate on new evidence for the risk of dementia and the risk of harm in the frail elderly\nDescribe how indication-based prescribing can help clinicians assess the patients who use anticholinergic drugs.\nUtilize informed consent to ensure patients are aware of the risks associated with use of anticholinergic drugs.
URL:https://scienceinvancouver.com/event/shedding-light-on-the-risks-of-anticholinergic-drugs-new-information-on-risk-of-dementia-and-harm-in-the-frail-elderly-4/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210714T114500
DTEND;TZID=America/Vancouver:20210714T124500
DTSTAMP:20260407T213449
CREATED:20210707T235225Z
LAST-MODIFIED:20210707T235225Z
UID:32571-1626263100-1626266700@scienceinvancouver.com
SUMMARY:Shedding Light On the Risks of Anticholinergic Drugs: New Information on Risk of Dementia and Harm In the Frail Elderly
DESCRIPTION:Dr. Aaron M Tejani is a researcher with the Therapeutics Initiative (co-chair of the Education Working Group and the Drug Assessment Working Group)\, a clinical assistant professor with the Faculty of Pharmaceutical Sciences (University of British Columbia)\, and Medication use evaluation pharmacist with Lower Mainland Pharmacy Services (Vancouver\, BC). He completed his BSc (Pharm) at UBC (Vancouver) and Doctor of Pharmacy degree at Creighton University (Omaha\, Nebraska). \nLearning Objectives \nBy the end of this session\, participants should be able to: \n\nUtilize existing tools to determine which drugs have anticholinergic properties.\nIdentify subtle and not-so-subtle manifestations on anticholinergic drug toxicity.\nUpdate on new evidence for the risk of dementia and the risk of harm in the frail elderly\nDescribe how indication-based prescribing can help clinicians assess the patients who use anticholinergic drugs.\nUtilize informed consent to ensure patients are aware of the risks associated with use of anticholinergic drugs.
URL:https://scienceinvancouver.com/event/shedding-light-on-the-risks-of-anticholinergic-drugs-new-information-on-risk-of-dementia-and-harm-in-the-frail-elderly-5/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210714T120000
DTEND;TZID=America/Vancouver:20210714T130000
DTSTAMP:20260407T213449
CREATED:20210707T232429Z
LAST-MODIFIED:20210707T232429Z
UID:17288-1626264000-1626267600@scienceinvancouver.com
SUMMARY:Silane-Mediated Direct Amide Bond Formation
DESCRIPTION:Join us to learn more about amazing research performed by Melissa D’Amaral\, Category: Drug Discovery — Oncology & Neuroscience Session III\n\n\n\n\n\nAbout this event\n\n\nSCWIST Symposium for Young Scientists \nOur Mini-Symposium for STEM students (See Eligibility Criteria) launches this summer\, under the vision and leadership of Dr. Noeen Malik\, Acting Director Events at SCWIST and chair of the symposium and Ashley van der Pouw Kraan\, symposium vice-chair. There will be 15 sessions\, held on YouTube Live\, every Wednesday at 12 pm PST from June to September. \nYou’ll be able to hear the personal experience of accomplished women in STEM companies who have made the successful careers in industry\, thrived the competition and have brought the cutting-edge technology to the world. \nThe Program layout will be: \n1. Introduction (SCWIST\, Judges\, Student) (10 min) (12:00-12:10 PM PST) \n2. Presentation by Speaker (12-15 min\, 12:10-12:25 PM PST) \n3. Panel Discussion (15 min\, 12:25-12:40 PM PST) \n3. Q & As from audience (15 min\, 12:40-12:55 PM PST) \n4. Closing remarks (5 min\, 12:55-13:00 PM PST)
URL:https://scienceinvancouver.com/event/silane-mediated-direct-amide-bond-formation/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210714T120000
DTEND;TZID=America/Vancouver:20210714T130000
DTSTAMP:20260407T213449
CREATED:20210707T232429Z
LAST-MODIFIED:20210707T232429Z
UID:26411-1626264000-1626267600@scienceinvancouver.com
SUMMARY:Silane-Mediated Direct Amide Bond Formation
DESCRIPTION:Join us to learn more about amazing research performed by Melissa D’Amaral\, Category: Drug Discovery — Oncology & Neuroscience Session III\n\n\n\n\n\nAbout this event\n\n\nSCWIST Symposium for Young Scientists \nOur Mini-Symposium for STEM students (See Eligibility Criteria) launches this summer\, under the vision and leadership of Dr. Noeen Malik\, Acting Director Events at SCWIST and chair of the symposium and Ashley van der Pouw Kraan\, symposium vice-chair. There will be 15 sessions\, held on YouTube Live\, every Wednesday at 12 pm PST from June to September. \nYou’ll be able to hear the personal experience of accomplished women in STEM companies who have made the successful careers in industry\, thrived the competition and have brought the cutting-edge technology to the world. \nThe Program layout will be: \n1. Introduction (SCWIST\, Judges\, Student) (10 min) (12:00-12:10 PM PST) \n2. Presentation by Speaker (12-15 min\, 12:10-12:25 PM PST) \n3. Panel Discussion (15 min\, 12:25-12:40 PM PST) \n3. Q & As from audience (15 min\, 12:40-12:55 PM PST) \n4. Closing remarks (5 min\, 12:55-13:00 PM PST)
URL:https://scienceinvancouver.com/event/silane-mediated-direct-amide-bond-formation-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210714T120000
DTEND;TZID=America/Vancouver:20210714T130000
DTSTAMP:20260407T213449
CREATED:20210707T232429Z
LAST-MODIFIED:20210707T232429Z
UID:28026-1626264000-1626267600@scienceinvancouver.com
SUMMARY:Silane-Mediated Direct Amide Bond Formation
DESCRIPTION:Join us to learn more about amazing research performed by Melissa D’Amaral\, Category: Drug Discovery — Oncology & Neuroscience Session III\n\n\n\n\n\nAbout this event\n\n\nSCWIST Symposium for Young Scientists \nOur Mini-Symposium for STEM students (See Eligibility Criteria) launches this summer\, under the vision and leadership of Dr. Noeen Malik\, Acting Director Events at SCWIST and chair of the symposium and Ashley van der Pouw Kraan\, symposium vice-chair. There will be 15 sessions\, held on YouTube Live\, every Wednesday at 12 pm PST from June to September. \nYou’ll be able to hear the personal experience of accomplished women in STEM companies who have made the successful careers in industry\, thrived the competition and have brought the cutting-edge technology to the world. \nThe Program layout will be: \n1. Introduction (SCWIST\, Judges\, Student) (10 min) (12:00-12:10 PM PST) \n2. Presentation by Speaker (12-15 min\, 12:10-12:25 PM PST) \n3. Panel Discussion (15 min\, 12:25-12:40 PM PST) \n3. Q & As from audience (15 min\, 12:40-12:55 PM PST) \n4. Closing remarks (5 min\, 12:55-13:00 PM PST)
URL:https://scienceinvancouver.com/event/silane-mediated-direct-amide-bond-formation-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210714T120000
DTEND;TZID=America/Vancouver:20210714T130000
DTSTAMP:20260407T213449
CREATED:20210707T232429Z
LAST-MODIFIED:20210707T232429Z
UID:31109-1626264000-1626267600@scienceinvancouver.com
SUMMARY:Silane-Mediated Direct Amide Bond Formation
DESCRIPTION:Join us to learn more about amazing research performed by Melissa D’Amaral\, Category: Drug Discovery — Oncology & Neuroscience Session III\n\n\n\n\n\nAbout this event\n\n\nSCWIST Symposium for Young Scientists \nOur Mini-Symposium for STEM students (See Eligibility Criteria) launches this summer\, under the vision and leadership of Dr. Noeen Malik\, Acting Director Events at SCWIST and chair of the symposium and Ashley van der Pouw Kraan\, symposium vice-chair. There will be 15 sessions\, held on YouTube Live\, every Wednesday at 12 pm PST from June to September. \nYou’ll be able to hear the personal experience of accomplished women in STEM companies who have made the successful careers in industry\, thrived the competition and have brought the cutting-edge technology to the world. \nThe Program layout will be: \n1. Introduction (SCWIST\, Judges\, Student) (10 min) (12:00-12:10 PM PST) \n2. Presentation by Speaker (12-15 min\, 12:10-12:25 PM PST) \n3. Panel Discussion (15 min\, 12:25-12:40 PM PST) \n3. Q & As from audience (15 min\, 12:40-12:55 PM PST) \n4. Closing remarks (5 min\, 12:55-13:00 PM PST)
URL:https://scienceinvancouver.com/event/silane-mediated-direct-amide-bond-formation-4/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210714T120000
DTEND;TZID=America/Vancouver:20210714T130000
DTSTAMP:20260407T213449
CREATED:20210707T232429Z
LAST-MODIFIED:20210707T232429Z
UID:32569-1626264000-1626267600@scienceinvancouver.com
SUMMARY:Silane-Mediated Direct Amide Bond Formation
DESCRIPTION:Join us to learn more about amazing research performed by Melissa D’Amaral\, Category: Drug Discovery — Oncology & Neuroscience Session III\n\n\n\n\n\nAbout this event\n\n\nSCWIST Symposium for Young Scientists \nOur Mini-Symposium for STEM students (See Eligibility Criteria) launches this summer\, under the vision and leadership of Dr. Noeen Malik\, Acting Director Events at SCWIST and chair of the symposium and Ashley van der Pouw Kraan\, symposium vice-chair. There will be 15 sessions\, held on YouTube Live\, every Wednesday at 12 pm PST from June to September. \nYou’ll be able to hear the personal experience of accomplished women in STEM companies who have made the successful careers in industry\, thrived the competition and have brought the cutting-edge technology to the world. \nThe Program layout will be: \n1. Introduction (SCWIST\, Judges\, Student) (10 min) (12:00-12:10 PM PST) \n2. Presentation by Speaker (12-15 min\, 12:10-12:25 PM PST) \n3. Panel Discussion (15 min\, 12:25-12:40 PM PST) \n3. Q & As from audience (15 min\, 12:40-12:55 PM PST) \n4. Closing remarks (5 min\, 12:55-13:00 PM PST)
URL:https://scienceinvancouver.com/event/silane-mediated-direct-amide-bond-formation-5/
LOCATION:Online
END:VEVENT
END:VCALENDAR